Buscar
Mostrando ítems 1-10 de 102
Effects of soy isoflavones on mammographic density and breast parenchyma in postmenopausal women: A randomized, double-blind, placebo-controlled clinical trial
(2013-10-01)
OBJECTIVE: This study aims to evaluate the effects of soy isoflavones on breast tissue in postmenopausal women. METHODS: In this randomized, double-blind, placebo-controlled study, 80 women (aged ≥45 y and with amenorrhea ...
Evaluation of mammographic density and Tc-99m-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy
(Elsevier B.V., 2006-01-10)
Objective: To evaluate changes in mammographic density and Tc-99m-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy (HRT).Methods: Seventy-five postmenopausal women were prospectively ...
Evaluation of mammographic density and Tc-99m-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy
(Elsevier B.V., 2006-01-10)
Objective: To evaluate changes in mammographic density and Tc-99m-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy (HRT).Methods: Seventy-five postmenopausal women were prospectively ...
Breast density in women with premature ovarian failure using hormone therapy
(Informa HealthcareNew YorkEUA, 2008)
Effects of soy isoflavones on mammographic density and breast parenchyma in postmenopausal women: A randomized, double-blind, placebo-controlled clinical trial
(2013-10-01)
OBJECTIVE: This study aims to evaluate the effects of soy isoflavones on breast tissue in postmenopausal women. METHODS: In this randomized, double-blind, placebo-controlled study, 80 women (aged ≥45 y and with amenorrhea ...
Evaluation of mammographic breast density in postmenopausal women on raloxifene
(Lippincott Williams & Wilkins, 2007-11-01)
Evaluation of mammographic breast density in postmenopausal women on raloxifene
(Lippincott Williams & Wilkins, 2007-11-01)